Shared on20 Sep 25
Fair value Increased 1.23%

With both future P/E and net profit margin remaining effectively unchanged, Encompass Health’s consensus analyst price target saw only a marginal increase from $135.75 to $137.42. What's in the News The New York Times reports Encompass Health, a leading rehab hospital operator, has had incidents of patient harm and underperforms on some Medicare safety measures, notably with higher unplanned readmissions, though it excels at helping patients return home; regulatory action and disclosure appear limited.

Shared on05 Sep 25

With both Net Profit Margin and Consensus Revenue Growth forecasts holding steady, analysts have kept their price target for Encompass Health unchanged at $135.75. What's in the News The New York Times reports that Encompass Health, a dominant for-profit rehab hospital operator, has had rare but serious incidents of patient harm and performs below average on certain Medicare safety measures, including high rates of unplanned readmissions, though it generally excels in helping patients return and stay home; federal enforcement and transparency are deemed limited (NY Times, 2025-07-15).